In a unanimous vote, the 21 members of the U.S. Food and Drug Administration (FDA)’s vaccine committee recommended an update to the COVID-19 vaccine to better match the viral strains currently circulating in the country and around the world.

The panel voted to move away from the current bivalent vaccine, which is designed to tackle the original virus and BA.4 and BA.5 variants, to a vaccine that is better able to protect against the XBB family of variantsคำพูดจาก สล็อตเว็บตรง. The half a dozen different versions of XBB viruses account for nearly all new infections in the U.S., with two—XBB.1.5 and XBB.1.16—currently dominating.

The group decided that…